ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,050.94
0.81%
US Tech 100
16,927.80
1.04%
Dow Jones
38,365.14
0.33%
Brent Oil
86.275
-0.16%
Bitcoin
66,913.74
0.08%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ocular Therapeutix Inc (OCUL)

  7. Ocular Therapeutix Inc (OCUL) News

Ocular Therapeutix Inc

Ocular Therapeutix Inc (OCUL)

NASDAQ
5.10
0.025
( 0.49% )
Updated: 10:08:49
Delayed by 15 minutes

Get an advanced news scanner tailored to your needs by ADVFN

Enhance your trading experience

OCUL News

Official News Only

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
March 11 2024
OCUL (0.49%)

Form 8-K - Current report
Edgar (US Regulatory)
March 11 2024
OCUL (0.49%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 27 2024
OCUL (0.49%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 26 2024
OCUL (0.49%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 26 2024
OCUL (0.49%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
February 26 2024
OCUL (0.49%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
February 26 2024
OCUL (0.49%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
February 22 2024
OCUL (0.49%)

Form 8-K - Current report
Edgar (US Regulatory)
February 22 2024
OCUL (0.49%)

OCUL Discussion

View Posts
Whalatane Whalatane 2 weeks ago
OCUL. P2 data 4/5/24
REUTERS
10:03 AM ET 04/06/2024
April 6 (Reuters) - Ocular Therapeutix Inc (OCUL):
* OCULAR THERAPEUTIX™ ANNOUNCES POSITIVE PHASE 2 PAXTRAVA™ GLAUCOMA DATA AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY 2024 ANNUAL MEETING
* OCULAR THERAPEUTIX INC (OCUL) - GENERALLY WELL TOLERATED WITH NO IMPACT ON CORNEAL HEALTH OBSERVED
* OCULAR THERAPEUTIX INC (OCUL) - CLINICALLY MEANINGFUL MEAN IOP REDUCTION OF ABOUT 24-30% FROM BASELINE OBSERVED OVER SIX MONTHS Source text for Eikon: Further company coverage:

Kiwi
👍️0
Monksdream Monksdream 3 weeks ago
OCUL under $10
👍️0
Monksdream Monksdream 1 month ago
OCUL 10Q due March 11
👍️0
glenn1919 glenn1919 4 months ago
OCUL....................................https://stockcharts.com/h-sc/ui?s=OCUL&p=W&b=5&g=0&id=p86431144783
👍️0
trendzone trendzone 1 year ago
Tard sells $6.00 call option at $0.15 at the close,apparently they were born yesterday.
👍️0
glenn1919 glenn1919 1 year ago
OCUL..........................................https://stockcharts.com/h-sc/ui?s=OCUL&p=W&b=5&g=0&id=p86431144783
👍️0
trendzone trendzone 1 year ago
Clueless fool sells $6.00 call option at $0.10 when they were just trading at $0.30,with the big rally going on in the stock today, what a total fool they are.
👍️0
cuggegrosse cuggegrosse 1 year ago
I chose OCUL to invest in because the market conditions should not effect the PPS(much),plus I can sell covered calls and make some monthly cash,besides they have products that are in demand !!!!
👍️ 1
cuggegrosse cuggegrosse 1 year ago
Yes I have noticed that
👍️ 1
Tzr250rg Tzr250rg 1 year ago
Ask is super thin wont take much to move. GLTUA
👍️0
cuggegrosse cuggegrosse 1 year ago
My eye doctor says Dextenza is a very good drug and he raccomends it !!!!!
👍️ 1
cuggegrosse cuggegrosse 1 year ago
DEXTENZA is doing very,very well,great revs expected in 2023
👍️ 1
cuggegrosse cuggegrosse 1 year ago
This company could go to $8.00 very eassy
👍️ 1
spotonge spotonge 2 years ago
boys need to wake up
👍️0
biotechslayr biotechslayr 2 years ago
Is anyone at all following OCUL into the end of the months binary? TKI data could be a game changer. Total TAM is ridiculous (look at REGN mcap!)
👍️ 1
oxnous oxnous 3 years ago
OCUL --charting


👍️0
oxnous oxnous 3 years ago
With the aging population, eye care is becoming an increasing concern. Dry eye, glaucoma, macular degeneration etc. will be expanding market sub sectors
👍️0
ClayTrader ClayTrader 3 years ago
* * $OCUL Video Chart 04-29-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
whytestocks whytestocks 3 years ago
Just In: $OCUL Ocular Therapeutix Announces Receipt of a Permanent Category I CPT Code from the American Medical Association for the Insertion of Intracanalicular Inserts

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that its application for the creation of a Category I Current Procedural Ter...

In case you are interested OCUL - Ocular Therapeutix Announces Receipt of a Permanent Category I CPT Code from the American Medical Association for the Insertion of Intracanalicular Inserts
👍️0
whytestocks whytestocks 4 years ago
Breaking News: $OCUL Ocular Therapeutix(TM) Announces Topline Phase 1 Clinical Trial Results of OTX-CSI

OTX-CSI demonstrates improvement in signs and symptoms of Dry Eye Disease Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the ey...

Got this from OCUL - Ocular Therapeutix(TM) Announces Topline Phase 1 Clinical Trial Results of OTX-CSI
👍️0
TheFinalCD TheFinalCD 4 years ago
OCUL 10.87 NEW HIGH OF DAY
👍️0
whytestocks whytestocks 4 years ago
Just In: $OCUL Ocular Therapeutix Announces Preliminary Net Product Revenue of $5.8 Million to $5.9 Million for Third Quarter 2020, Representing Greater Than a 250% Increase Over the Previous Quarter

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today reported preliminary, unaudited net product revenue for the third quarter ended Septe...

Find out more OCUL - Ocular Therapeutix Announces Preliminary Net Product Revenue of $5.8 Million to $5.9 Million for Third Quarter 2020, Representing Greater Than a 250% Increase Over the Previous Quarter
👍️0
now invest now invest 4 years ago
Thus far OCUL is trading nicely!!
👍️0
ClayTrader ClayTrader 4 years ago
* * $OCUL Video Chart 05-22-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 4 years ago
* * $OCUL Video Chart 03-04-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
edwardport edwardport 4 years ago
near term 10% projected increase in market price

closed on 2/7/20 @ $5.21
👍️0
ClayTrader ClayTrader 4 years ago
* * $OCUL Video Chart 02-07-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 4 years ago
* * $OCUL Video Chart 01-03-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 4 years ago
* * $OCUL Video Chart 11-29-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
TFMG TFMG 5 years ago
OCUL - POSSIBLE 25% TREND MOVE ON THE DAILY

Ocular Therapeutix , Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

SHORT INTEREST
8.24M 07/15/19

P/E Current
-2.78

P/E Ratio (with extraordinary items)
-2.92

Average Recommendation: OVERWEIGHT

Average Target Price: 9.67

👍️0
tste9 tste9 5 years ago
Great news! BUT, hoped for more volume price etc. wow
GLA
👍️0
ClayTrader ClayTrader 5 years ago
* * $OCUL Video Chart 07-26-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
whytestocks whytestocks 5 years ago
News: $OCUL Ocular Therapeutix(TM) Announces Early Assignment of Permanent and Specific J-Code (J1096) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4mg by the Centers for Medicare and Medicaid Services

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a ...

Got this from Ocular Therapeutix(TM) Announces Early Assignment of Permanent and Specific J-Code (J1096) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4mg by the Centers for Medicare and Medicaid Services
👍️0
smallbio smallbio 5 years ago

Is DEXTENZA currently only targeting medicare patients, as there is no private insurance company will reimburse the cost?
👍️0
tste9 tste9 5 years ago
What is up with this little piggy, lately! #&*#@*
👍️0
tste9 tste9 5 years ago
Great news thanks for post. Do you know of any web site that posts OCUL sales per week. Thank you. GL
👍️0
whytestocks whytestocks 5 years ago
News: $OCUL Ocular Therapeutix(TM) Announces Commercial Launch of DEXTENZA® (dexamethasone intracanalicular insert) 0.4 mg for Ophthalmic Use in the United States

Pass-through payment status and C-code from the Centers for Medicare and Medicaid Services (CMS) now active Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and ...

In case you are interested https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-commercial-launch-of-dextenza-x-8439742.html
👍️0
swingingRichard swingingRichard 5 years ago
Shorted 10,000 shares. Looking good.
👍️0
tste9 tste9 5 years ago
Shorts ease out as usual. criminal how shorts manipulate SP then just slither out unharmed. GLA
👍️0
tste9 tste9 5 years ago
YEA BABY!
👍️0
ClayTrader ClayTrader 5 years ago
* * $OCUL Video Chart 06-21-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
whytestocks whytestocks 5 years ago
News: $OCUL Ocular Therapeutix(TM) Announces FDA Approval of Supplemental New Drug Application (sNDA) for DEXTENZA® (0.4 Dexamethasone Intracanalicular Insert for Ophthalmic Use) for the Treatment of Ocular Inflammation Following Ophthalmic Surgery

DEXTENZA ® Now Approved for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases...

Find out more https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-fda-approval-of-supplemental-new-drug-application-snda-for-dextenza-xae-0-4-dexamethasone-intracanalicular-insert-for-ophthalmic-use-for-the-treatment-of-ocular-inflammation-following-ophthalmic-surgery-8394606.html
👍️0
ClayTrader ClayTrader 5 years ago
* * $OCUL Video Chart 06-11-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
Tzr250rg Tzr250rg 5 years ago
low volume today
👍️0
whytestocks whytestocks 5 years ago
News: $OCUL Ocular Therapeutix(TM) Announces Receipt of C-Code and Pass-Through Payment Status for DEXTENZA®

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Centers for Medicare and Medicaid Services (CMS) has approved t...

Got this from https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-receipt-of-c-code-and-pass-through-payment-status-for-dextenza-xae--8261962.html
👍️0
ClayTrader ClayTrader 5 years ago
* * $OCUL Video Chart 05-21-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
now invest now invest 5 years ago
Stopped in to see anything up.... oh well...
👍️0
RolandDoe RolandDoe 5 years ago
Hardly
👍️0
Rakbors Rakbors 5 years ago
No
👍️0
RickieK RickieK 5 years ago
Hellooooo is there anyone here
👍️0

Your Recent History

NASDAQ
OCUL
Ocular Therapeutix
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved